Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Sep:128:358-366.
doi: 10.1016/j.neubiorev.2021.06.038. Epub 2021 Jun 29.

Behavioral sex differences in cocaine and opioid use disorders: The role of gonadal hormones

Melissa C Knouse  1 , Lisa A Briand  2
Affiliations
Review

Behavioral sex differences in cocaine and opioid use disorders: The role of gonadal hormones

Melissa C Knouse et al. Neurosci Biobehav Rev. 2021 Sep.

Abstract

Females are more vulnerable than males to many aspects of cocaine use disorder. This vulnerability also translates to opioid use disorder, with females exhibiting stronger behavioral responses than males to drugs such as heroin and morphine. While there is evidence for many overlapping neural mechanisms underlying cocaine and opioid abuse, there is also a breadth of evidence indicating divergent effects of the drugs on synaptic plasticity. This makes it unclear whether the behavioral sex differences seen in substance use disorder across different drugs of abuse rely on the same mechanisms. Ovarian hormones have consistently been implicated as drivers of the behavioral sex differences in cocaine taking and seeking. While there are far fewer studies on the role of ovarian hormones in opioid use disorder, the existing data suggest that ovarian hormones may not drive these behavioral effects in the same manner as in cocaine use disorder. This review highlights evidence that behavioral sex differences in substance use disorder might be driven by different mechanisms depending on drug class.

Keywords: Cocaine; Estradiol; Opioids; Sex differences; Substance use disorder; Testosterone.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Arnold AP, 2009. The organizational-activational hypothesis as the foundation for a unified theory of sexual differentiation of all mammalian tissues. Horm Behav 55, 570–578. - PMC - PubMed
    1. Back SE, Payne RL, Wahlquist AH, Carter RE, Stroud Z, Haynes L, Hillhouse M, Brady KT, Ling W, 2011. Comparative profiles of men and women with opioid dependence: results from a national multisite effectiveness trial. Am J Drug Alcohol Abuse 37, 313–323. - PMC - PubMed
    1. Baker DA, McFarland K, Lake RW, Shen H, Tang XC, Toda S, Kalivas PW, 2003. Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse. Nat Neurosci 6, 743–749. - PubMed
    1. Baptista MA, Martin-Fardon R, Weiss F, 2004. Preferential effects of the metabotropic glutamate 2/3 receptor agonist LY379268 on conditioned reinstatement versus primary reinforcement: comparison between cocaine and a potent conventional reinforcer. J Neurosci 24, 4723–4727. - PMC - PubMed
    1. Bechard AR, Hamor PU, Schwendt M, Knackstedt LA, 2018. The effects of ceftriaxone on cue-primed reinstatement of cocaine-seeking in male and female rats: estrous cycle effects on behavior and protein expression in the nucleus accumbens. Psychopharmacology (Berl) 235, 837–848. - PMC - PubMed

Publication types